# A Phase 2 Study Evaluating The Efficacy And Safety Of PF 04494700 In Mild To Moderate Alzheimer's Disease

> **NCT00566397** · PHASE2 · COMPLETED · sponsor: **Pfizer** · enrollment: 402 (actual)

## Conditions studied

- Alzheimer's Disease

## Interventions

- **DRUG:** PF-04494700
- **DRUG:** PF-04494700
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00566397
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-12
- **Primary completion:** 2010-12
- **Final completion:** 2010-12
- **Target enrollment:** 402 (ACTUAL)
- **Last updated:** 2018-11-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00566397

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00566397, "A Phase 2 Study Evaluating The Efficacy And Safety Of PF 04494700 In Mild To Moderate Alzheimer's Disease". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT00566397. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*